About
Chau Q. Khuong is a Senior Advisor at Catalio. Chau Khuong has experience in start-up operations and business development at Veritas Medicine, Inc. and in basic science research at the Yale School of Medicine and at Massachusetts General Hospital. He was a summer Associate in the New Ventures technology transfer group at Columbia University. At OrbiMed, Chau Khuong was actively involved investments in Arius Research, Inc. (acquired by Roche in 2008), Peninsula Pharmaceuticals, Inc. (acquired by Johnson & Johnson, Inc., in 2005), Cerexa, Inc. (acquired by Forest Laboratories, Inc., in 2007), Adiana, Inc. (acquired by Cytyc Corporation in 2007), Avanir (NASDAQ: AVNR), and Biodel, Inc. (NASDAQ: BIOD). He currently serves as Director or Observer on the Corporate Boards at Cerapedics, Glaukos Corporation, Intercept Pharma, Sonendo, and Pieris AG. Chau Khuong holds a BS in molecular biology with concentration in biotechnology and an MPH with concentration in infectious diseases, both fro
Investment Focus
- Location
- New York, US
Contact Information
Find more investors like Chau
Search Investors